BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Update

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 40,700 shares, a growth of 38.9% from the May 15th total of 29,300 shares. Based on an average daily trading volume, of 35,300 shares, the short-interest ratio is currently 1.2 days.

BioStem Technologies Price Performance

BSEM stock traded up 0.19 on Friday, hitting 7.35. The company’s stock had a trading volume of 13,000 shares, compared to its average volume of 12,900. BioStem Technologies has a 1 year low of 1.20 and a 1 year high of 15.50. The firm’s 50 day simple moving average is 9.07.

BioStem Technologies (OTCMKTS:BSEM) last released its quarterly earnings data on Tuesday, May 14th. The company reported 0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of 0.74 by -0.54. The firm had revenue of 41.90 million during the quarter, compared to the consensus estimate of 12.70 million. As a group, analysts anticipate that BioStem Technologies will post 0.49 earnings per share for the current year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.